摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-chloro-9-[(2,3-O-isopropylidene)-4-thio-β-D-ribofuranosyl]purine | 900810-21-1

中文名称
——
中文别名
——
英文名称
6-chloro-9-[(2,3-O-isopropylidene)-4-thio-β-D-ribofuranosyl]purine
英文别名
((3aS,4R,6R,6aR)-6-(6-chloro-9H-purin-9-yl)-2,2-dimethyltetrahydrothieno[3,4-d][1,3]dioxol-4-yl)methanol;[(3aR,4R,6R,6aS)-4-(6-chloropurin-9-yl)-2,2-dimethyl-3a,4,6,6a-tetrahydrothieno[3,4-d][1,3]dioxol-6-yl]methanol
6-chloro-9-[(2,3-O-isopropylidene)-4-thio-β-D-ribofuranosyl]purine化学式
CAS
900810-21-1
化学式
C13H15ClN4O3S
mdl
——
分子量
342.806
InChiKey
MZIAEYNEEKDDCI-WOUKDFQISA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    22
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    7

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design, synthesis, and biological activity of N6-substituted-4′-thioadenosines at the human A3 adenosine receptor
    摘要:
    A large series of N-6-substituted-4'-thioadenosines were synthesized starting from D-gulonic-gamma-Iactone, and structure-activity relationships were studied at the human A(3) and other subtypes of adenosine receptors (ARs). 2-Chloro-substituted and 2-H analogues were compared. 2-Chloro-N-6-methyl-4'-thioadeno sine 19b was a highly potent and selective agonist (K-i = 0.8 +/- 0.1 nM in binding) at the A(3)AR, and displayed the same relative efficacy in receptor activation as a known full agonist, Cl-IB-MECA. Most of N6-substituted-4'-thioadenosines were less potent in binding than the corresponding N-6-substituted-adenosines or N-6-substituted-4'thioadenosine-5'-uronamides. N-6-(3-lodobenzyl) derivative 19g was demonstrated to be an A(3)AR-selective partial agonist displaying a Ki value of 3.2 nM. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.03.030
  • 作为产物:
    描述:
    benzoic acid (3aS,4R,6R,6aR)-6-(6-chloro-purin-9-yl)-2,2-dimethyl-tetrahydro-thieno[3,4-d][1,3]dioxol-4-ylmethyl ester甲基碘化镁 作用下, 以 四氢呋喃乙醚 为溶剂, 反应 4.0h, 以62%的产率得到6-chloro-9-[(2,3-O-isopropylidene)-4-thio-β-D-ribofuranosyl]purine
    参考文献:
    名称:
    Design, synthesis, and biological activity of N6-substituted-4′-thioadenosines at the human A3 adenosine receptor
    摘要:
    A large series of N-6-substituted-4'-thioadenosines were synthesized starting from D-gulonic-gamma-Iactone, and structure-activity relationships were studied at the human A(3) and other subtypes of adenosine receptors (ARs). 2-Chloro-substituted and 2-H analogues were compared. 2-Chloro-N-6-methyl-4'-thioadeno sine 19b was a highly potent and selective agonist (K-i = 0.8 +/- 0.1 nM in binding) at the A(3)AR, and displayed the same relative efficacy in receptor activation as a known full agonist, Cl-IB-MECA. Most of N6-substituted-4'-thioadenosines were less potent in binding than the corresponding N-6-substituted-adenosines or N-6-substituted-4'thioadenosine-5'-uronamides. N-6-(3-lodobenzyl) derivative 19g was demonstrated to be an A(3)AR-selective partial agonist displaying a Ki value of 3.2 nM. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2006.03.030
点击查看最新优质反应信息

文献信息

  • [EN] CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS<br/>[FR] COMPOSÉS DINUCLÉOTIDIQUES CYCLIQUES UTILISÉS COMME AGONISTES STING
    申请人:MERCK SHARP & DOHME
    公开号:WO2019125974A1
    公开(公告)日:2019-06-27
    A class of polycyclic compounds of general formula (I), wherein Base1, Base2, Y, Za, Xa, Xa1, Xb, Xb1, Xc, Xc1, Xd, Xd1, R1, R1a, R2, R2a, R3, R4, R4a, R5, R6, R6a, R7, R7a, R8, R8a, and R9 are defined herein, that may be useful as inductors of type I interferon production, specifically as STING active agents, are provided. Also provided are processes for the synthesis and use of compounds.
    一类具有通用公式(I)的多环化合物的类别,其中Base1,Base2,Y,Za,Xa,Xa1,Xb,Xb1,Xc,Xc1,Xd,Xd1,R1,R1a,R2,R2a,R3,R4,R4a,R5,R6,R6a,R7,R7a,R8,R8a和R9按本说明书中定义,可能对作为I型干扰素产生的诱导剂特别有用,具体作为STING激活剂。还提供了合成和使用化合物的过程。
  • CYCLIC DI-NUCLEOTIDE COMPOUNDS AS STING AGONISTS
    申请人:MERCK SHARP & DOHME CORP.
    公开号:EP3727401A1
    公开(公告)日:2020-10-28
查看更多